Reimbursement for Genetic Variant Reinterpretation: Five Questions Payers Should Ask
Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies.
Systematic Review of Comparative Effectiveness Data for Oncology Orphan Drugs
This study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.
Toward Evidence-based Assessment for Coverage and Reimbursement of Laboratory-based Diagnostic and Genetic Tests
Genetic Testing and Pharmacogenomics: Issues for Determining the Impact to Healthcare Delivery and Costs
Managed Care in the Genomics Era: Assessing the Cost Effectiveness of Genetic Tests
